CTLA4 and neoplasm: Camelid‐derived, nanobodies targeting PD‐L1 and CTLA‐4, expressed in probiotic E. coli, provided a means of specific delivery achieving selective intra‐tumoural bacterial colonization and therapeutic efficacy in murine tumour models.92